×

Antagonists of IL-6 to raise albumin and/or lower crp

  • US 20130183264A1
  • Filed: 02/28/2013
  • Published: 07/18/2013
  • Est. Priority Date: 11/25/2008
  • Status: Active Grant
First Claim
Patent Images

1. ) A method of improving survivability or quality of life of a patient in need thereof, comprising administering to the patient an IL-6 antagonist, whereby the patient'"'"'s serum C-reactive protein (“

  • CRP”

    ) level is reduced, and monitoring the patient to assess the reduction in the patient'"'"'s serum CRP level.

View all claims
  • 10 Assignments
Timeline View
Assignment View
    ×
    ×